Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Current Assets (2016 - 2025)

Historic Current Assets for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to $5.1 million.

  • CV Sciences' Current Assets fell 2446.65% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 2446.65%. This contributed to the annual value of $6.2 million for FY2024, which is 2135.3% down from last year.
  • Per CV Sciences' latest filing, its Current Assets stood at $5.1 million for Q3 2025, which was down 2446.65% from $5.9 million recorded in Q2 2025.
  • Over the past 5 years, CV Sciences' Current Assets peaked at $17.5 million during Q1 2021, and registered a low of $5.1 million during Q3 2025.
  • Over the past 5 years, CV Sciences' median Current Assets value was $8.5 million (recorded in 2023), while the average stood at $10.1 million.
  • In the last 5 years, CV Sciences' Current Assets tumbled by 4318.5% in 2021 and then tumbled by 1173.5% in 2025.
  • Quarter analysis of 5 years shows CV Sciences' Current Assets stood at $14.2 million in 2021, then decreased by 21.54% to $11.1 million in 2022, then dropped by 28.68% to $7.9 million in 2023, then dropped by 21.35% to $6.2 million in 2024, then fell by 18.36% to $5.1 million in 2025.
  • Its Current Assets was $5.1 million in Q3 2025, compared to $5.9 million in Q2 2025 and $6.0 million in Q1 2025.